NORGESIC

Main information

  • Trade name:
  • NORGESIC 35 mg / 450 mg tablet
  • Dosage:
  • 35 mg / 450 mg
  • Pharmaceutical form:
  • tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • NORGESIC 35 mg / 450 mg tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Orphenadrine, combinations
  • Product summary:
  • Suitability for use in older adult patients Paracetamolum Suitable for older persons. Maximum dose in regular use 3 g/ day. Overdose is hepatotoxic. Take into account the risk of bleeding with warfarin, when the dose of paracetamol exceeds 2 grams a day in regular use. Concurrent use with warfarin is possible if INR values are monitored. Note paracetamol in OTC drugs and combination products. Orphenadrini citras Avoid using in older persons. Anticholinergic. Slightly sedative. Significant adverse effects include xerostomia, constipation, dizziness, tachycardia, urinary difficulties, confusion and cognitive disporder. Weakens the efficacy of anti-Alzheimer`s drugs.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 3382
  • Authorization date:
  • 16-02-2009
  • Last update:
  • 21-02-2018